NASDAQ : VCYT
Veracyte, Inc. — Financial statements
Healthcare · Diagnostics & Research · United States
Last price 50.01 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 4.02B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Veracyte, Inc. (VCYT) reported revenue of 561.90M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 561.90M | 517.14M | 445.76M | 361.05M | 296.54M | 219.51M |
| Cost of Revenue | 147.46M | 143.95M | 136.07M | 112.90M | 101.58M | 74.40M |
| Gross Profit | 414.44M | 373.20M | 309.70M | 248.15M | 194.95M | 145.11M |
| Selling, General & Admin | 215.28M | 226.24M | 203.88M | 193.10M | 170.61M | 180.38M |
| Research & Development | 93.37M | 70.81M | 69.29M | 57.30M | 40.60M | 29.84M |
| Amortization of Goodwill & Intangibles | 13.11M | 13.15M | 14.85M | 20.57M | 21.35M | 15.98M |
| Operating Expenses | 321.75M | 310.21M | 288.02M | 270.98M | 232.56M | 226.21M |
| Operating Income | 92.68M | 62.99M | 21.68M | -22.83M | -37.61M | -81.09M |
| Interest Expense | -1.00K | -2.00K | -15.00K | -198.00K | -241.00K | |
| Interest & Investment Income | 14.39M | 12.72M | 11.15M | 7.34M | 1.97M | 135.00K |
| Currency Exchange Gain (Loss) | -1.24M | 3.97M | -2.04M | 723.00K | 197.00K | -1.08M |
| Other Non Operating Income (Expenses) | 3.81M | 436.00K | 495.00K | 1.13M | 2.68M | 1.44M |
| EBT Excluding Unusual Items | 109.64M | 80.12M | 31.28M | -13.65M | -32.95M | -80.84M |
| Gain (Loss) on Sale of Assets | -6.71M | -6.71M | ||||
| Asset Writedown | -20.50M | -3.37M | -68.35M | -3.32M | ||
| Other Unusual Items | 13.08M | 15.29M | -2.17M | 5.38M | -154.00K | -810.00K |
| Pretax Income | 116.02M | 68.20M | 25.74M | -76.61M | -36.43M | -81.65M |
| Income Tax Expense | 1.54M | 1.85M | 1.61M | -2.21M | 133.00K | -6.09M |
| Net Income | 114.48M | 66.35M | 24.14M | -74.40M | -36.56M | -75.56M |
| Net Income to Common | 114.48M | 66.35M | 24.14M | -74.40M | -36.56M | -75.56M |
| Shares Outstanding (Basic) | 79.36M | 78.58M | 76.48M | 72.64M | 71.55M | 67.89M |
| Shares Outstanding (Diluted) | 81.50M | 80.57M | 78.16M | 72.64M | 71.55M | 67.89M |
| EPS (Basic) | 1.44 | 0.84 | 0.32 | -1.02 | -0.51 | -1.11 |
| EPS (Diluted) | 1.39 | 0.82 | 0.31 | -1.02 | -0.51 | -1.11 |
| Free Cash Flow | 165.99M | 126.63M | 63.81M | 34.26M | -1.01M | -37.00M |
| Free Cash Flow Per Share | 2.04 | 1.57 | 0.82 | 0.47 | -0.01 | -0.55 |
| Gross Margin | 73.76% | 72.17% | 69.48% | 68.73% | 65.74% | 66.11% |
| Operating Margin | 16.50% | 12.18% | 4.86% | -6.32% | -12.68% | -36.94% |
| Profit Margin | 20.37% | 12.83% | 5.42% | -20.61% | -12.33% | -34.42% |
| Free Cash Flow Margin | 29.54% | 24.49% | 14.31% | 9.49% | -0.34% | -16.85% |
| EBITDA | 113.52M | 84.40M | 45.14M | 4.36M | -11.68M | -61.50M |
| EBITDA Margin | 20.20% | 16.32% | 10.13% | 1.21% | -3.94% | -28.02% |
| D&A For EBITDA | 20.83M | 21.41M | 23.46M | 27.19M | 25.93M | 19.59M |
| EBIT | 92.68M | 62.99M | 21.68M | -22.83M | -37.61M | -81.09M |
| EBIT Margin | 16.49% | 12.18% | 4.86% | -6.32% | -12.68% | -36.94% |
| Effective Tax Rate | 1.32% | 2.71% | 6.24% | |||
| Revenue as Reported | 561.90M | 517.14M | 445.76M | 361.05M | 296.54M | 219.51M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 299.52M | 362.58M | 239.09M | 216.45M | 154.25M | 173.20M |
| Short-Term Investments | 185.71M | 50.31M | 50.35M | 24.61M | 3.96M | |
| Cash & Short-Term Investments | 485.23M | 412.89M | 289.44M | 216.45M | 178.85M | 177.16M |
| Accounts Receivable | 54.18M | 44.66M | 46.52M | 40.38M | 44.02M | 41.46M |
| Receivables | 54.18M | 44.66M | 46.52M | 40.38M | 44.02M | 41.46M |
| Inventory | 22.66M | 20.55M | 21.75M | 16.13M | 14.29M | 11.22M |
| Prepaid Expenses | 12.71M | 10.28M | 14.55M | 12.66M | 11.47M | 13.26M |
| Total Current Assets | 574.77M | 488.38M | 372.27M | 285.62M | 248.64M | 243.10M |
| Property, Plant & Equipment | 57.10M | 58.79M | 71.14M | 30.86M | 30.86M | 31.14M |
| Goodwill | 767.15M | 767.15M | 745.80M | 702.98M | 695.89M | 707.90M |
| Other Intangible Assets | 82.70M | 89.15M | 102.30M | 88.59M | 174.87M | 202.73M |
| Other Long-Term Assets | 3.01M | 2.55M | 8.53M | 6.85M | 6.17M | 2.95M |
| Total Assets | 1.49B | 1.41B | 1.30B | 1.11B | 1.16B | 1.19B |
| Accounts Payable | 8.02M | 4.59M | 8.63M | 12.94M | 11.91M | 12.36M |
| Accrued Expenses | 47.68M | 48.80M | 43.83M | 38.43M | 37.77M | 39.48M |
| Current Portion of Long-Term Debt | 1.13M | |||||
| Current Portion of Leases | 5.78M | 4.05M | 7.50M | 5.11M | 4.07M | 3.63M |
| Current Unearned Revenue | 597.00K | 1.16M | 1.67M | 2.01M | 2.61M | 4.65M |
| Other Current Liabilities | 662.00K | 1.33M | 17.00M | 2.76M | 6.25M | 2.91M |
| Total Current Liabilities | 62.74M | 59.94M | 78.63M | 61.24M | 62.61M | 64.15M |
| Long-Term Leases | 34.33M | 35.60M | 43.24M | 7.53M | 11.05M | 14.70M |
| Long-Term Unearned Revenue | 343.00K | |||||
| Long-Term Deferred Tax Liabilities | 637.00K | 646.00K | 1.23M | 734.00K | 4.53M | 5.59M |
| Other Long-Term Liabilities | 259.00K | 257.00K | 972.00K | 1.30M | 3.03M | 6.53M |
| Total Liabilities | 97.96M | 96.44M | 124.07M | 70.80M | 81.22M | 91.31M |
| Common Stock | 80.00K | 79.00K | 78.00K | 73.00K | 72.00K | 71.00K |
| Additional Paid-In Capital | 1.72B | 1.70B | 1.66B | 1.54B | 1.50B | 1.47B |
| Retained Earnings | -323.43M | -377.63M | -443.98M | -468.12M | -393.72M | -357.16M |
| Comprehensive Income & Other | -7.94M | -8.21M | -36.09M | -24.02M | -31.35M | -15.08M |
| Shareholders' Equity | 1.39B | 1.31B | 1.18B | 1.04B | 1.08B | 1.10B |
| Total Liabilities & Equity | 1.49B | 1.41B | 1.30B | 1.11B | 1.16B | 1.19B |
| Total Debt | 40.11M | 39.65M | 50.74M | 12.63M | 15.12M | 19.45M |
| Net Cash (Debt) | 445.12M | 373.24M | 238.70M | 203.82M | 163.73M | 157.71M |
| Net Cash Per Share | 5.46 | 4.63 | 3.05 | 2.81 | 2.29 | 2.32 |
| Filing Date Shares Outstanding | 80.39M | 79.46M | 77.94M | 75.07M | 72.15M | 71.22M |
| Total Common Shares Outstanding | 80.36M | 79.36M | 77.77M | 73.26M | 71.96M | 71.12M |
| Working Capital | 512.04M | 428.44M | 293.63M | 224.38M | 186.02M | 178.95M |
| Book Value Per Share | 17.28 | 16.50 | 15.12 | 14.25 | 14.94 | 15.42 |
| Tangible Book Value | 538.55M | 453.27M | 327.87M | 252.53M | 204.44M | 185.88M |
| Tangible Book Value Per Share | 6.70 | 5.71 | 4.22 | 3.45 | 2.84 | 2.61 |
| Machinery | 46.44M | 44.73M | 33.81M | 26.71M | 22.35M | |
| Construction In Progress | 106.00K | 2.46M | 587.00K | 999.00K | ||
| Leasehold Improvements | 12.38M | 10.62M | 10.31M | 9.74M | 8.61M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 114.48M | 66.35M | 24.14M | -74.40M | -36.56M | -75.56M |
| Depreciation & Amortization | 20.83M | 21.41M | 23.46M | 27.19M | 25.93M | 19.59M |
| Loss (Gain) From Sale of Assets | 7.08M | 6.72M | 202.00K | 271.00K | 206.00K | |
| Asset Writedown & Restructuring Costs | 20.50M | 3.37M | 68.35M | 3.32M | ||
| Loss (Gain) From Sale of Investments | -2.68M | -3.27M | -354.00K | -468.00K | ||
| Stock-Based Compensation | 48.51M | 43.60M | 36.25M | 33.14M | 26.73M | 22.52M |
| Other Operating Activities | -9.77M | -16.72M | 9.00M | -6.16M | 4.29M | -2.39M |
| Change in Accounts Receivable | -6.15M | -708.00K | -6.41M | 3.89M | -4.50M | -8.57M |
| Change in Inventory | -2.11M | -2.86M | -5.87M | -1.69M | -3.01M | -1.46M |
| Change in Accounts Payable | -394.00K | -1.04M | -4.30M | -134.00K | 152.00K | 5.16M |
| Change in Other Net Operating Assets | 8.59M | 2.31M | -4.38M | -5.75M | -9.03M | 9.10M |
| Operating Cash Flow | 178.38M | 136.31M | 75.10M | 44.22M | 7.54M | -31.62M |
| Capital Expenditures | -12.39M | -9.68M | -11.29M | -9.96M | -8.55M | -5.38M |
| Cash Acquisitions | 5.01M | -736.83M | ||||
| Divestitures | -2.85M | -2.85M | ||||
| Investment in Securities | -81.81M | 3.31M | -50.00M | 25.07M | -20.84M | 3.00M |
| Investing Cash Flow | -98.67M | -9.21M | -56.27M | 15.11M | -29.39M | -739.21M |
| Long-Term Debt Repaid | -1.28M | |||||
| Net Debt Issued (Repaid) | -1.28M | |||||
| Issuance of Common Stock | 20.47M | 14.08M | 19.99M | 9.58M | 7.94M | 605.35M |
| Repurchase of Common Stock | -20.13M | -18.30M | -10.59M | -6.74M | -3.17M | -9.03M |
| Other Financing Activities | -4.50M | |||||
| Financing Cash Flow | 338.00K | -4.22M | 4.90M | 2.84M | 3.49M | 596.32M |
| Foreign Exchange Rate Adjustments | -12.00K | 719.00K | -424.00K | 163.00K | -592.00K | -1.51M |
| Net Cash Flow | 80.03M | 123.59M | 23.30M | 62.33M | -18.95M | -176.02M |
| Free Cash Flow | 165.99M | 126.63M | 63.81M | 34.26M | -1.01M | -37.00M |
| Free Cash Flow Margin | 29.54% | 24.49% | 14.31% | 9.49% | -0.34% | -16.85% |
| Free Cash Flow Per Share | 2.04 | 1.57 | 0.82 | 0.47 | -0.01 | -0.55 |
| Levered Free Cash Flow | 106.23M | 86.80M | 63.31M | 34.30M | 15.79M | -9.52M |
| Unlevered Free Cash Flow | 106.23M | 86.80M | 63.31M | 34.31M | 15.91M | -9.37M |
| Cash Interest Paid | 9.00K | 9.00K | ||||
| Cash Income Tax Paid | 3.60M | 3.64M | 2.24M | 1.70M | 570.00K | 112.00K |
| Change in Working Capital | -62.00K | -2.30M | -20.96M | -3.69M | -16.38M | 4.22M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 3.94B | 3.33B | 3.07B | 2.01B | 1.70B | 2.93B |
| Enterprise Value | 3.49B | 3.00B | 2.81B | 1.82B | 1.55B | 2.78B |
| Last Close Price | 49.00 | 42.10 | 39.60 | 27.51 | 23.73 | 41.20 |
| PE Ratio | 35.14 | 50.16 | 127.14 | |||
| Forward PE | 27.41 | 27.08 | 43.53 | |||
| PS Ratio | 7.01 | 6.43 | 6.88 | 5.57 | 5.74 | 13.33 |
| PB Ratio | 2.84 | 2.54 | 2.61 | 1.92 | 1.58 | 2.67 |
| P/TBV Ratio | 7.31 | 7.34 | 9.36 | 7.96 | 8.33 | 15.75 |
| P/FCF Ratio | 23.73 | 26.28 | 48.10 | 58.65 | ||
| P/OCF Ratio | 22.08 | 24.41 | 40.87 | 45.44 | 225.97 | |
| PEG Ratio | 0.73 | 1.24 | ||||
| EV/Sales Ratio | 6.22 | 5.80 | 6.31 | 5.04 | 5.23 | 12.65 |
| EV/EBITDA Ratio | 30.78 | 35.57 | 62.36 | 417.68 | ||
| EV/EBIT Ratio | 37.70 | 47.66 | 129.85 | |||
| EV/FCF Ratio | 21.05 | 23.71 | 44.11 | 53.14 | ||
| Debt / Equity Ratio | 0.03 | 0.03 | 0.04 | 0.01 | 0.01 | 0.02 |
| Debt / EBITDA Ratio | 0.30 | 0.38 | 0.82 | 1.31 | ||
| Debt / FCF Ratio | 0.24 | 0.31 | 0.80 | 0.37 | ||
| Net Debt / Equity Ratio | -0.32 | -0.28 | -0.20 | -0.20 | -0.15 | -0.14 |
| Net Debt / EBITDA Ratio | -3.92 | -4.42 | -5.29 | -46.76 | 14.02 | 2.56 |
| Net Debt / FCF Ratio | -2.68 | -2.95 | -3.74 | -5.95 | 161.47 | 4.26 |
| Asset Turnover | 0.40 | 0.38 | 0.37 | 0.32 | 0.25 | 0.27 |
| Inventory Turnover | 6.19 | 6.81 | 7.18 | 7.42 | 7.96 | 9.37 |
| Quick Ratio | 8.60 | 7.63 | 4.27 | 4.19 | 3.56 | 3.41 |
| Current Ratio | 9.16 | 8.15 | 4.73 | 4.66 | 3.97 | 3.79 |
| Return on Equity (ROE) | 8.77% | 5.34% | 2.17% | -7.02% | -3.37% | -9.96% |
| Return on Assets (ROA) | 4.09% | 2.91% | 1.12% | -1.26% | -2.00% | -6.16% |
| Return on Invested Capital (ROIC) | 9.69% | 6.54% | 2.29% | -2.61% | -4.06% | -15.85% |
| Return on Capital Employed (ROCE) | 6.50% | 4.70% | 1.80% | -2.20% | -3.40% | -7.20% |
| Earnings Yield | 2.85% | 1.99% | 0.79% | -3.70% | -2.15% | -2.58% |
| FCF Yield | 4.21% | 3.81% | 2.08% | 1.70% | -0.06% | -1.26% |
| Buyback Yield / Dilution | -2.11% | -3.08% | -7.60% | -1.53% | -5.39% | -27.52% |